Evaluation of the 2005 McDonald MRI criteria for dissemination in space in Afro-Caribbean patients with clinically isolated syndromes

European Journal of Neurology

Volumn 16, Issue 11, 2009, Pages 1191-1196

  Chausson, N ^a   Olindo, S ^a   Signate A ^a   Smadja, D ^a   Cabre, P ^a  

^a CENTRE HOSPITALIER UNIVERSITAIRE DE FORT DE FRANCE   (France)

Author keywords

African descent; Blacks; Dissemination in space; McDonald criteria; Multiple sclerosis

Indexed keywords

GADOLINIUM;

ADULT; AFRICAN CARIBBEAN; ARTICLE; BRAIN; BRAIN STEM; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; ETHNIC GROUP; FEMALE; HUMAN; IMAGING SYSTEM; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC NEURITIS; PREDICTION; PRIORITY JOURNAL; SPINAL CORD; SPINE;

ADOLESCENT; ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGE OF ONSET; BRAIN; CHILD; DEMYELINATING DISEASES; DIAGNOSIS, DIFFERENTIAL; DISEASE PROGRESSION; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MARTINIQUE; MIDDLE AGED; NERVE FIBERS, MYELINATED; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SPINAL CORD;

EID: 70350134053     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2009.02691.x     Document Type: Article

References (23)

1. Tintoré M, Rovira A, Río J, et al. New diagnostic criteria for multiple sclerosis: application in first demyelinating episode. Neurology 2003 60 : 27 30.
2. Cree BA, Khan O, Bourdette D, et al. Clinical characteristics of African Americans vs Caucasian Americans with multiple sclerosis. Neurology 2004 63 : 2039 2045. (Pubitemid 39636249)
3. Chan LL, Sitoh YY, Chong J, et al. Application of the McDonald MRI criteria in multiple sclerosis. Ann Acad Med Singapore 2007 36 : 647 654.
4. Polman CH, Reingold SC, Edan G, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Ann Neurol 2005 58 : 840 846.
5. Monplaisir N, Valette I, Lepage V, et al. Study of HLA antigens of the Martinican population. Tissue Antigens 1985 26 : 1 11.
6. Cabre P, Signate A, Olindo S, et al. Role of return migration in the emergence of multiple sclerosis in the French West Indies. Brain 2005 128 : 2899 2910.
7. Miller DH, Weinshenker BG, Filippi M, et al. Differential diagnosis of suspected multiple sclerosis: a consensus approach. Mult Scler 2008 14 : 1157 1174.
8. Wingerchuk DM, Hogancamp WF, O'Brien PC, et al. The clinical course of neuromyelitis optica (Devic's syndrome). Neurology 1999 53 : 1107 1114.
9. Swanton JK, Rovira A, Tintore M, et al. MRI criteria for multiple sclerosis in patients presenting with clinically isolated syndromes: a multicentre retrospective study. Lancet Neurol 2007 6 : 677 686.
10. Gallo A, Rovaris M, Benedetti B, et al. A brain magnetization transfer MRI study with a clinical follow up of about four years in patients with clinically isolated syndromes suggestive of multiple sclerosis. J Neurol 2007 254 : 78 83.
11. Kaufman MD, Johnson SK, Moyer D, et al. Multiple sclerosis: severity and progression rate in African Americans compared with whites. Am J Phys Med Rehabil 2003 82 : 582 590.
12. Jacobs LD, Beck RW, Simon JH, et al. Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. CHAMPS Study Group. N Engl J Med 2000 28 : 343.
13. Comi G, Filippi M, Barkhof F, et al. Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study. Lancet 2001 357 : 1576 1582.
14. Kappos L, Freedman MS, Polman CH, et al. Effect of early versus delayed interferon beta-1b treatment on disability after a first clinical event suggestive of multiple sclerosis: a 3-year follow-up analysis of the BENEFIT study. Lancet 2007 370 : 389 397.
15. Kira J, Kanai T, Nishimura Y, et al. Western versus Asian types of multiple sclerosis: immunogenetically and clinically distinct disorders. Ann Neurol 1996 40 : 569 574.
16. Yamasaki K, Horiuchi I, Minohara M, et al. HLA-DPB1*0501-associated opticospinal multiple sclerosis: clinical, neuroimaging and immunogenetic studies. Brain 1999 122 : 1689 1696.
17. Cabre P, Heinzlef O, Merle H, et al. MS and neuromyelitis optica in Martinique (French West Indies). Neurology 2001 56 : 507 514.
18. Tintoré M, Rovira A, Río J, et al. Do oligoclonal bands add information to MRI in first attacks of multiple sclerosis? Neurology 2008 70 : 1079 1083.
19. Brex PA, Ciccarelli O, O'Riordan JI, et al. A longitudinal study of abnormalities on MRI and disability from multiple sclerosis. N Engl J Med 2002 346 : 158 164.
20. O'Riordan JI, Thompson AJ, Kingsley DP, et al. The prognostic value of brain MRI in clinically isolated syndromes of the CNS. A 10-year follow-up. Brain 1998 121 : 495 503.
21. Bot JC, Barkhof F, Polman CH, et al. Spinal cord abnormalities in recently diagnosed MS patients: added value of spinal MRI examination. Neurology 2004 62 : 226 233.
22. Bot JC, Barkhof F, Lycklama à Nijeholt G, et al. Differentiation of multiple sclerosis from other inflammatory disorders and cerebrovascular disease: value of spinal MR imaging. Radiology 2002 223 : 46 56.
23. Swanton JK, Fernando K, Dalton CM, et al. Modification of MRI criteria for multiple sclerosis in patients with clinically isolated syndromes. J Neurol Neurosurg Psychiatry 2006 77 : 830 833. (Pubitemid 44023177)